SCHEMBL11297519

SCHEMBL11297519

O=C(NO)c1ccc(N(c2ccc(Oc3ccccc3)cc2)C2CCNC2=O)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 5/20 0.43
▸ HDAC8 Q9BY41 4/20 0.43
▸ HDAC1 Q13547 2/20 0.43
▸ MMP1 P03956 2/20 0.43
▸ MMP13 P45452 2/20 0.41
▸ MMP2 P08253 1/20 0.41
▸ MMP7 P09237 1/20 0.41
▸ MMP9 P14780 1/20 0.41
▸ EZH2 Q15910 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ PGR P06401 1/20 0.39
▸ USP30 Q70CQ3 2/20 0.38
▸ KDM1A O60341 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ MAPK14 Q16539 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11301404 0.93 HDAC8 (0.47) HDAC6HDAC8HDAC1MMP1MMP13
SCHEMBL11304336 0.84 HDAC6 (0.42) HDAC6HDAC8HDAC1MMP13
SCHEMBL11306357 0.83 ALDH1A1 (0.46) HDAC6HDAC8HDAC1ALDH1A1KDM4E
SCHEMBL11297424 0.83 HDAC1 (0.43) HDAC6HDAC8HDAC1ALDH1A1SMN1; SMN2
SCHEMBL11296174 0.83 HDAC8 (0.44) HDAC6HDAC8HDAC1SMN1; SMN2NPC1
SCHEMBL11301754 0.82 PSEN1 (0.42) HDAC6HDAC8HDAC1ALDH1A1POLB
SCHEMBL11305647 0.82 HDAC6 (0.41) HDAC6HDAC8HDAC1KDM4EKDM1A
SCHEMBL11297375 0.81 HDAC8 (0.44) HDAC6HDAC8HDAC1KDM4ELMNA
SCHEMBL11297369 0.81 HDAC6 (0.40) HDAC6HDAC8HDAC1ALDH1A1KDM4E
SCHEMBL11296049 0.81 HDAC6 (0.45) HDAC6HDAC8HDAC1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback